EXCEL CROP CARE has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Mar-18* | 3 Dec-18* | 3 Mar-19* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 2,073 | 2,320 | 2,732 | 17.8% | 31.8% |
Other income | Rs m | 7 | 4 | 3 | -13.6% | -49.8% |
Turnover | Rs m | 2,080 | 2,324 | 2,736 | 17.7% | 31.5% |
Expenses | Rs m | 2,025 | 2,252 | 2,614 | 16.1% | 29.1% |
Gross profit | Rs m | 49 | 68 | 118 | 73.9% | 142.6% |
Depreciation | Rs m | 45 | 45 | 50 | 12.0% | 10.7% |
Interest | Rs m | 8 | 1 | 6 | 455.2% | -29.9% |
Profit before tax | Rs m | 2 | 26 | 65 | 153.1% | 4188.2% |
Tax | Rs m | 7 | 1 | 18 | 1523.6% | 164.2% |
Profit after tax | Rs m | -5 | 25 | 47 | 92.0% | |
Gross profit margin | % | 2.3 | 2.9 | 4.3 | ||
Effective tax rate | % | 444.7 | 4.3 | 27.4 | ||
Net profit margin | % | -0.3 | 1.1 | 1.7 |
To see how EXCEL CROP CARE has performed over the last eight quarters, please visit here.
Over the last one year, EXCEL CROP CARE share price has moved up from Rs 3,153.9 to Rs 3,132.0, registering a Loss of Rs 21.9 or around 0.7%.
Overall, the S&P BSE SENSEX is up 11.9% over the year.
At the current price of Rs 3,132.0, the price to earnings (P/E) ratio of EXCEL CROP CARE stands at 39.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.5 times.
For the quarter ended June 2019, EXCEL CROP CARE has posted a net profit of Rs 236 m (down 38.7% YoY). Sales on the other hand came in at Rs 4 bn (down 5.2% YoY). Read on for a complete analysis of EXCEL CROP CARE's quarterly results.
For the quarter ended December 2018, EXCEL CROP CARE has posted a net profit of Rs 25 m (down 80.9% YoY). Sales on the other hand came in at Rs 2 bn (down 10.3% YoY). Read on for a complete analysis of EXCEL CROP CARE's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More
| |
Equitymaster requests your view! Post a comment on "EXCEL CROP CARE Announces Quarterly Results (4QFY19); Net Profit Up 1003.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!